# Stop Infliximab in Patients With Crohn's Disease

> **NCT00571337** · PHASE3 · COMPLETED · sponsor: **Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives** · enrollment: 126 (actual)

## Conditions studied

- Crohn Disease

## Interventions

- **DRUG:** Infliximab

## Key facts

- **NCT ID:** NCT00571337
- **Lead sponsor:** Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 126 (ACTUAL)
- **Last updated:** 2010-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00571337

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00571337, "Stop Infliximab in Patients With Crohn's Disease". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00571337. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*